Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids
收藏干细胞与再生医学数据中心2022-02-20 更新2024-03-06 收录
下载链接：
http://data.iscr.ac.cn/Article?id=e797ef41061f36a2e2efb2d6b4a34fdf
下载链接
链接失效反馈官方服务：
资源简介：
The SARS-CoV-2 virus has caused already over 3.5 million COVID-19 cases and 250,000 deaths globally. There is an urgent need to create novel models to study SARS-CoV-2 using human disease-relevant cells to understand key features of virus biology and facilitate drug screening. As primary SARS-CoV-2 infection is respiratory-based, we developed a lung organoid model using human pluripotent stem cells (hPSCs) that could be adapted for drug screens.
提供机构：
Weill Cornell Medical College
创建时间：
2022-02-20
